Sotorasib in KRAS G12C-mutated non-small cell lung carcinoma

被引：0
|
作者：
Lorenz, Judith
机构：
来源：
PNEUMOLOGIE | 2023年 / 77卷 / 11期
关键词：
D O I：
10.1055/a-2111-0905
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Menschen mit einem fortgeschrittenen nichtkleinzelligen Lungenkarzinom (NSCLC) haben eine schlechte uberlebensprognose. Liegt eine KRAS G12C-Mutation vor, profitieren sie den Ergebnissen der CodeBreak 100-Studie zu Folge von Sotorasib, einem spezifischen und irreversiblen KRAS-Inhibitor. Nun berichten die Studieninitiatorinnen und -initiatoren die 2-Jahres-Datenauswertung bezuglich der Effektivitat, der Sicherheit sowie molekularer Biomarker.
引用
收藏
页码：846 / 846
页数：1
相关论文
共 50 条
  • [41] KontRASt-01 Update: Safety and Efficacy of JDQ443 in KRAS G12C-Mutated Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC)
    Cassier, P.
    Dooms, C.
    Gazzah, A.
    Felip, E.
    Steeghs, N.
    Rohrberg, K. S.
    De Braud, F.
    Solomon, B.
    Schuler, M.
    Tan, D. S.
    Yamamoto, N.
    Loong, H. H. F.
    Cho, B. C.
    Wolf, J.
    Lin, C. C.
    Negrao, M. V.
    Werner, L.
    Cui, X.
    Farago, A. F.
    DeMiguel, M. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (01): : E4 - E5
  • [42] KontRASt-01 update: safety and efficacy of JDQ443 in KRAS G12C-mutated solid tumors including non-small cell lung cancer (NSCLC)
    Schuler, M.
    Cassier, P. A.
    Dooms, C.
    Gazzah, A.
    Felip, E.
    Steeghs, N.
    Rohrberg, K. S.
    De Braud, F.
    Solomon, B.
    Tan, D. S.
    Yamamoto, N.
    Loong, H. H.
    Cho, B. C.
    Wolf, J.
    Lin, C. -C
    Negrao, M.
    Werner, L.
    Cui, X.
    Farago, A. F.
    de Miguel, M. J.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 147 - 148
  • [43] KontRASt-01 update: Safety and efficacy of JDQ443 in KRAS G12C-mutated solid tumors including non-small cell lung cancer (NSCLC)
    Cassier, Philippe Alexandre
    Dooms, Christophe Alfons
    Gazzah, Anas
    Felip, Enriqueta
    Steeghs, Neeltje
    Rohrberg, Kristoffer Staal
    De Braud, Filippo G.
    Solomon, Benjamin J.
    Schuler, Martin H.
    Tan, Daniel Shao-Weng
    Yamamoto, Noboru
    Loong, Herbert H. F.
    Cho, Byoung Chul
    Wolf, Juergen
    Lin, Chia-Chi
    Negrao, Marcelo Vailati
    Werner, Lillian
    Cui, Xiaoming
    Farago, Anna F.
    de Miguel, Maria J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] Rapid Response to Sotorasib of a Patient With KRAS G12C-Mutated Lung Cancer With Cancer-Associated Disseminated Intravascular Coagulation: A Case Report
    Kunimasa, Kei
    Tamiya, Motohiro
    Inoue, Takako
    Kawamura, Takahisa
    Nishino, Kazumi
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (01):
  • [45] Cost-Effectiveness Analysis of Sotorasib vs. Adagrasib in KRAS G12c-Mutated Previously Treated NSCLC
    Karim, N.
    Waterhouse, D.
    Jones, S.
    Stollenwerk, B.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S719 - S720
  • [46] Adagrasib (MRTX849) in patients with advanced/metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC): Preliminary analysis of mutation allele frequency
    Janne, P. A.
    Spira, A.
    Riely, G. J.
    Gadgeel, S.
    Heist, R.
    Ou, S-H. I.
    Johnson, M. L.
    Sabari, J.
    Velastegui, K.
    Christensen, J. G.
    Yang, W.
    Anderes, K.
    Chao, R.
    Paweletz, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S41 - S42
  • [47] Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100
    Dy, Grace K. K.
    Govindan, Ramaswamy
    Velcheti, Vamsidhar
    Falchook, Gerald S. S.
    Italiano, Antoine
    Wolf, Jurgen
    Sacher, Adrian G. G.
    Takahashi, Toshiaki
    Ramalingam, Suresh S. S.
    Dooms, Christophe
    Kim, Dong-Wan
    Addeo, Alfredo
    Desai, Jayesh
    Schuler, Martin
    Tomasini, Pascale
    Hong, David S. S.
    Lito, Piro
    Tran, Qui
    Jones, Simon
    Anderson, Abraham
    Hindoyan, Antreas
    Snyder, Wendy
    Skoulidis, Ferdinandos
    Li, Bob T. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (18) : 3311 - +
  • [48] Intracranial efficacy of sotorasib versus docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC): Practice-informing data from a global, phase 3, randomized, controlled trial (RCT)
    Dingemans, Anne-Marie C.
    Syrigos, Konstantinos
    Livi, Lorenzo
    Paulus, Astrid
    Kim, Sang-We
    Chen, Yuanbin
    Felip, Enriqueta
    Griesinger, Frank
    Ohashi, Kadoaki
    Zalcman, Gerard
    Hughes, Brett Gordon Maxwell
    Sorensen, Jens Benn
    Blais, Normand
    Ferreira, Carlos G. M.
    Lindsay, Colin R.
    Dziadziuszko, Rafal
    Ward, Patrick J.
    Obiozor, Cynthia Chinedu
    Wang, Yang
    Peters, Solange
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (17_SUPPL) : LBA9016 - LBA9016
  • [49] Intracranial efficacy of sotorasib versus docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC): Practice-informing data from a global, phase 3, randomized, controlled trial (RCT)
    Dingemans, Anne-Marie C.
    Syrigos, Konstantinos
    Livi, Lorenzo
    Paulus, Astrid
    Kim, Sang-We
    Chen, Yuanbin
    Felip, Enriqueta
    Griesinger, Frank
    Ohashi, Kadoaki
    Zalcman, Gerard
    Hughes, Brett Gordon Maxwell
    Sorensen, Jens Benn
    Blais, Normand
    Ferreira, Carlos G. M.
    Lindsay, Colin R.
    Dziadziuszko, Rafal
    Ward, Patrick J.
    Obiozor, Cynthia Chinedu
    Wang, Yang
    Peters, Solange
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (17)
  • [50] Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer
    Alessandro Di Federico
    Ilaria Ricciotti
    Valentina Favorito
    Sandra Vietti Michelina
    Pietro Scaparone
    Giulio Metro
    Andrea De Giglio
    Federica Pecci
    Giuseppe Lamberti
    Chiara Ambrogio
    Biagio Ricciuti
    Current Oncology Reports, 2023, 25 : 1017 - 1029
12345